Effectiveness of oral pressure therapy in obstructive sleep apnea: a systematic analysis

2015 ◽  
Vol 20 (2) ◽  
pp. 663-671 ◽  
Author(s):  
Gaurav Nigam ◽  
Charu Pathak ◽  
Muhammad Riaz
SLEEP ◽  
2014 ◽  
Vol 37 (7) ◽  
pp. 1237-1247 ◽  
Author(s):  
Richard J. Schwab ◽  
C. Kim ◽  
Lawrence Siegel ◽  
B.T. Keenan ◽  
Jed Black ◽  
...  

2013 ◽  
Vol 14 (9) ◽  
pp. 830-837 ◽  
Author(s):  
Ian M. Colrain ◽  
Jed Black ◽  
Lawrence C. Siegel ◽  
Richard K. Bogan ◽  
Philip M. Becker ◽  
...  

2016 ◽  
Vol 20 (3) ◽  
pp. 1011-1012 ◽  
Author(s):  
Macario Camacho ◽  
Sungjin A. Song ◽  
Anthony M. Tolisano

Author(s):  
Atul Malhotra ◽  
Richard K. Bogan ◽  
Mehran Farid-Moayer ◽  
Philip M. Becker ◽  
Rochelle Goldberg ◽  
...  

2021 ◽  
Vol 22 (5) ◽  
pp. 2300
Author(s):  
Ronni Baran ◽  
Daniela Grimm ◽  
Manfred Infanger ◽  
Markus Wehland

Obstructive sleep apnea (OSA) is a common disease, with approximately 3–7% of men and 2–5% of women worldwide suffering from symptomatic OSA. If OSA is left untreated, hypoxia, microarousals and increased chemoreceptor stimulation can lead to complications like hypertension (HT). Continuous positive airway pressure (CPAP) is the most common treatment for OSA, and it works by generating airway patency, which will counteract the apnea or hypopnea. More than one billion people in the world suffer from HT, and the usual treatment is pharmacological with antihypertensive medication (AHM). The focus of this review will be to investigate whether the CPAP therapy for OSA affects HT.


Sign in / Sign up

Export Citation Format

Share Document